Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Abby L Olsen

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Glia|July 4, 2019
Glial α-synuclein promotes neurodegeneration characterized by a distinct transcriptional program in vivoAbby L Olsen, Mel B Feany
The New England Journal of Medicine|January 31, 2019
PARP Inhibitors and Parkinson's DiseaseAbby L Olsen, Mel B Feany
Current Opinion in Neurology|July 14, 2020
Immunotherapy in progressive supranuclear palsyPavan A Vaswani, Abby L Olsen
Neurobiology of Disease|August 14, 2021
Parkinson's disease risk genes act in glia to control neuronal α-synuclein toxicityAbby L Olsen, Mel B Feany
JAMA Neurology|May 1, 2018
Discovering New Benefits From Old Drugs With Big Data-Promise for Parkinson DiseaseAbby L Olsen, Trond Riise, Clemens R Scherzer
Journal of Parkinson'S Disease|July 10, 2025
Proposed mechanisms of neuroprotection for nicotine in Parkinson's diseaseNamrata Kumari, Lauren E Cooke, Abby L Olsen
Journal of Visualized Experiments : Jove|October 9, 2023
Measuring Constipation in a Drosophila Model of Parkinson's DiseaseMaggie J Sodders, Ming Shen, Abby L Olsen
Blood|October 29, 2005
Designer blood: creating hematopoietic lineages from embryonic stem cellsAbby L Olsen, David L Stachura, Mitchell J Weiss
Movement Disorders : Official Journal of the Movement Disorder Society|November 23, 2022
Nicotine-Mediated Rescue of α-Synuclein Toxicity Requires Synaptic Vesicle Glycoprotein 2 in DrosophilaAbby L Olsen, Sabrina G Clemens, Mel B Feany
Movement Disorders Clinical Practice|January 8, 2026
Posterior Encephalopathy Syndrome in a Patient with Multiple System Atrophy and Multiple MyelomaJackson Mitzner, Jenny Linnoila, Yanal Shaheen, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Glia|July 4, 2019
Glial α-synuclein promotes neurodegeneration characterized by a distinct transcriptional program in vivoAbby L Olsen, Mel B Feany
The New England Journal of Medicine|January 31, 2019
PARP Inhibitors and Parkinson's DiseaseAbby L Olsen, Mel B Feany
Current Opinion in Neurology|July 14, 2020
Immunotherapy in progressive supranuclear palsyPavan A Vaswani, Abby L Olsen
Neurobiology of Disease|August 14, 2021
Parkinson's disease risk genes act in glia to control neuronal α-synuclein toxicityAbby L Olsen, Mel B Feany
JAMA Neurology|May 1, 2018
Discovering New Benefits From Old Drugs With Big Data-Promise for Parkinson DiseaseAbby L Olsen, Trond Riise, Clemens R Scherzer
Journal of Parkinson'S Disease|July 10, 2025
Proposed mechanisms of neuroprotection for nicotine in Parkinson's diseaseNamrata Kumari, Lauren E Cooke, Abby L Olsen
Journal of Visualized Experiments : Jove|October 9, 2023
Measuring Constipation in a Drosophila Model of Parkinson's DiseaseMaggie J Sodders, Ming Shen, Abby L Olsen
Blood|October 29, 2005
Designer blood: creating hematopoietic lineages from embryonic stem cellsAbby L Olsen, David L Stachura, Mitchell J Weiss
Movement Disorders : Official Journal of the Movement Disorder Society|November 23, 2022
Nicotine-Mediated Rescue of α-Synuclein Toxicity Requires Synaptic Vesicle Glycoprotein 2 in DrosophilaAbby L Olsen, Sabrina G Clemens, Mel B Feany
Movement Disorders Clinical Practice|January 8, 2026
Posterior Encephalopathy Syndrome in a Patient with Multiple System Atrophy and Multiple MyelomaJackson Mitzner, Jenny Linnoila, Yanal Shaheen, et al.
Pageof 3